Supportive Care in Cancer最新文献

{"title":"Standardized gynecologic consultation and bone surveillance in patients with breast cancer receiving hormone therapy.","authors":"Ching-Wen Chiu, Chih-Ming Su, Li-Min Liao, Yun-Ting Su, Hsueh-Chi Wu, Ka-Wai Tam","doi":"10.1007/s00520-025-09543-1","DOIUrl":"https://doi.org/10.1007/s00520-025-09543-1","url":null,"abstract":"<p><strong>Objective: </strong>Long-term use of hormone therapy may increase the risks of endometrial cancer and osteoporosis in patients with breast cancer. To minimize these risks, breast surgeons should schedule early consultations with gynecologists and arrange bone mineral density (BMD) examinations. In this study, we used the plan-do-study-act (PDSA) methodology to enhance comprehensive care coordination with the gynecology department and promote early surveillance of bone loss in patients with breast cancer undergoing hormone therapy.</p><p><strong>Methods: </strong>We conducted a workshop and implemented standardized interventions that included gynecologic consultations and BMD examinations. We tracked the rates of these interventions during sequential PDSA cycles in 2023 and compared them with baseline rates from 2020 to 2022. We also evaluated the adjustment rate of therapy in patients with osteoporosis after undergoing BMD examinations.</p><p><strong>Results: </strong>Before our interventions were implemented, the baseline 6-month rate of gynecologic consultations was 36%. This rate increased to 76.3% and 75% during PDSA cycles 1 and 2, respectively. Similarly, the rate of BMD examinations increased from 29.3 to 40% during PDSA cycle 1. Among patients who received a diagnosis of osteoporosis after a BMD examination, the rate of those who altered their hormone therapy increased from 11% before the PDSA cycles to 19% during the cycles.</p><p><strong>Conclusion: </strong>Our standardized intervention successfully raises awareness among all practitioners and promotes comprehensive care for patients with breast cancer receiving hormone therapy. Future PDSA cycles should focus on developing implementation strategies aimed at enhancing electronic medical record systems to better identify patients at risk.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"479"},"PeriodicalIF":2.8,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of synbiotic mouthwash on salivary TLR2 levels and oral mucositis in head and neck cancer patients undergoing radiotherapy: a randomized clinical trial.","authors":"Maryam Koopaie, Sahar Vaziri, Soheila Manifar, Shima Younespour, Sajad Kolahdooz","doi":"10.1007/s00520-025-09522-6","DOIUrl":"https://doi.org/10.1007/s00520-025-09522-6","url":null,"abstract":"<p><strong>Purpose: </strong>Head and neck squamous cell carcinoma (HNSCC) is a common type of malignancy that is often treated with radiotherapy. This treatment can lead to the development of oral mucositis. This study investigates the effectiveness of a synbiotic mouthwash in reducing the severity of oral mucositis and in modulating salivary toll-like receptor 2 (TLR2) levels in HNSCC patients undergoing radiotherapy.</p><p><strong>Materials and methods: </strong>A triple-blind, placebo-controlled randomized clinical trial was conducted on 44 HNSCC patients, randomly assigned to either a synbiotic mouthwash (synbiotic group) or a normal saline mouthwash (placebo group). Salivary TLR2 levels were measured at baseline and after the completion of radiotherapy and oral mucositis treatment using an enzyme-linked immunosorbent assay (ELISA). The severity of oral mucositis was evaluated at each follow-up session using the MASCC/ISOO grading system. Statistical analyses included generalized estimating equations and Kaplan-Meier survival curves.</p><p><strong>Results: </strong>Compared to the placebo group, the synbiotic group showed a significant delay in the onset of oral mucositis in grades II and III. Patients in the synbiotic group experienced a slower progression to severe mucositis, with a longer duration of grade II mucositis and fewer cases of grade III mucositis. Moreover, the mean salivary level of TLR2 in patients significantly decreased by the end of the study. However, the two groups found no statistically significant difference in salivary TLR2 levels.</p><p><strong>Conclusions: </strong>The synbiotic mouthwash significantly reduced the severity of oral mucositis and delayed its progression in HNSCC patients undergoing radiotherapy. TLR2 levels decreased significantly in both groups. IRCT20230624058564N1, registration date: 2023-08-06. https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02591897/full https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20230624058564N1 http://en.irct.ir/trial/70874.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"481"},"PeriodicalIF":2.8,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mapping cancer patient online support groups: enhancing patient care in a low-middle income healthcare system.","authors":"Fatma Bektash, Heba Hossam Ouda, Yasmine Hassan, Asmaa El-Sayed, Emad Shash","doi":"10.1007/s00520-025-09535-1","DOIUrl":"10.1007/s00520-025-09535-1","url":null,"abstract":"<p><p>Cancer's impact extends beyond the physical domain, affecting patients' psychological, social, and financial well-being. Consequently, cancer support groups have a crucial role in guiding patients through their cancer journey and improving their quality of life. However, in Egypt, patient support groups remain undervalued and lack comprehensive visibility. This study aimed to address this gap by mapping patient online support groups in Egypt, categorizing them, and highlighting their importance in supporting patients and caregivers. The research includes examining online support groups and pages, particularly on Facebook. The results of our investigation indicate that 21% of the Facebook groups examined met the criteria for classification as qualified, another 21% were categorized as semi-qualified, while most of the groups, comprising 58%, were considered non-qualified. For the Facebook pages examined, organizational involvement through governmental, non-governmental, and charitable institutions qualified these pages as meeting the criteria for qualification. In contrast, the majority (70%) of the analyzed community pages were non-qualified, 30% were semi-qualified, and none met the criteria for qualification. This underscores the need for discernment when engaging with online resources. Furthermore, the study illuminates the role of various organizations, including hospitals, non-governmental organizations (NGOs), and pharmaceutical companies, in supporting cancer patients, especially through online support groups. Despite these efforts, comprehensive review articles on Egyptian patient support groups are lacking, making this study a significant contribution to understanding and enhancing patient support in the fight against cancer.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"480"},"PeriodicalIF":2.8,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12089213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of compression therapy for prevention of peripheral neuropathy caused by taxane-based chemotherapy: a single-center retrospective observational study.","authors":"Yuko Kanbayashi, Takeshi Ishikawa, Yusuke Tabuchi, Kazuko Sugatani, Tetsuya Taguchi, Koichi Takayama","doi":"10.1007/s00520-025-09527-1","DOIUrl":"https://doi.org/10.1007/s00520-025-09527-1","url":null,"abstract":"<p><strong>Introduction: </strong>Chemotherapy-induced peripheral neuropathy (CIPN) is a significant complication of taxane-based chemotherapies that limits their clinical utility. This study evaluated the effectiveness of compression therapy using surgical gloves in preventing CIPN in various cancer types, including, but not limited to, breast cancer.</p><p><strong>Patients and methods: </strong>Data from 603 patients who underwent taxane-based chemotherapy at a single institution between April 2018 and January 2024 were retrospectively analyzed. Variables associated with CIPN development were extracted and analyzed using uni- and multivariate ordered logistic regression models.</p><p><strong>Result: </strong>Compression therapy was significantly associated with a reduced incidence of CIPN. Significant predictors of CIPN included lung cancer (odds ratio [OR] = 0.342, P = 0.003), number of chemotherapy cycles (OR = 1.015, P = 0.033), and use of surgical gloves (OR = 0.559, P = 0.003).</p><p><strong>Conclusion: </strong>Compression therapy using simple, cost-effective surgical gloves appeared effective for preventing CIPN in a diverse cancer population undergoing taxane-based chemotherapy. The risk of CIPN increases with the number of chemotherapy cycles, and a lower incidence was observed among patients with lung cancer. These findings provide a foundation for future research aimed at improving patient quality of life during taxane-based chemotherapy.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"478"},"PeriodicalIF":2.8,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to: Exploring the impact of breast cancer support groups on survivorship and treatment decision‑making in Eastern Ethiopia: a qualitative study.","authors":"Nahom G Belete, Meera Bhakta, Tara Wilfong, Mahlet Shewangizaw, Edilawit Abebaw Abera, Yehenaw Tenaw, Michael Shawel, Habtamu Seife, Biruk Habtamu, Nahom Wondwossen, Elizabeth A Wood","doi":"10.1007/s00520-025-09538-y","DOIUrl":"10.1007/s00520-025-09538-y","url":null,"abstract":"","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"477"},"PeriodicalIF":2.8,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12084238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sleep quality trajectories and their relationship with quality of life in patients with hepatocellular carcinoma: a prospective cohort study.","authors":"Fan-Rong Li, Rong-Rui Huo, Feng-Juan Zhao, Jian-Hong Zhong, Xue-Mei You","doi":"10.1007/s00520-025-09518-2","DOIUrl":"https://doi.org/10.1007/s00520-025-09518-2","url":null,"abstract":"<p><strong>Purpose: </strong>To identify the classes of sleep quality trajectories in patients with hepatocellular carcinoma (HCC) and analyze differences in patient characteristics across these classes and to explore the relationship between sleep quality trajectory and quality of life (QOL) in patients.</p><p><strong>Methods: </strong>A total of 205 patients completed sleep quality assessments at four time points (before surgery and 1, 3, and 6 months after surgery). Classes of heterogeneous sleep quality trajectories were identified using a latent class mixed-effects model. The differences in the characteristics of patients across classes were identified by unordered multicategorical logistic regression. The relationship between sleep quality trajectory and QOL was assessed using a generalized estimation equation model.</p><p><strong>Results: </strong>Three latent classes of sleep quality trajectories were identified in HCC patients: persistent good sleep (19.5%); persistent poor sleep (75.6%); and worsening (4.9%). Depression, fatigue, comorbidities, and drinking were associated with an increased odds of belonging to the persistent poor sleep class compared to the persistent good sleep class. Tumor size ≥ 5 cm and comorbidities were associated with an increased odds of belonging to the worsening class. The decreases in QOL from admission to 1, 3, and 6 months after surgery were significantly higher for patients in the worsening class compared to patients in the persistent good sleep class (all P < 0.001).</p><p><strong>Conclusion: </strong>The sleep quality trajectories in patients with HCC were characterized by three latent classes; patients in these classes differed in disease characteristics, psychological, and physical symptoms. Sleep quality worsening can lead to significant declines in the QOL of patients after surgery.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"476"},"PeriodicalIF":2.8,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving our understanding of the quality of life of patients with metastatic or recurrent/persistent anal cancer: a systematic review.","authors":"Samantha C Sodergren, Rowan Edwards, Rahul Krishnatry, Marianne G Guren, Kristopher Dennis, Pierfrancesco Franco, Francesca de Felice, Anne-Sophie Darlington, Vassilios Vassiliou","doi":"10.1007/s00520-025-09520-8","DOIUrl":"10.1007/s00520-025-09520-8","url":null,"abstract":"<p><strong>Purpose: </strong>Chemoradiation (CRT) is used to treat anal carcinomas which, for most patients with loco-regional disease, results in a cure but is associated with acute and chronic complications impairing quality of life (QoL). Patients with metastatic disease or recurrence are likely to experience additional QoL concerns. This paper identifies the QoL issues of these patients and determines whether the EORTC QLQ-ANL27 (QLQ-ANL27), a measure of QoL of patients treated with CRT for anal cancer used alongside the core EORTC QLQ-C30 (QLQ-C30), is suitable or needs adapting.</p><p><strong>Methods: </strong>A systematic review was conducted of studies published between 2014 and 2024 reporting QoL of patients with metastatic or recurrent/persistent anal cancer or follow-up data of patients treated with CRT for anal cancer.</p><p><strong>Results: </strong>This review included 23 papers, only three focused exclusively on metastatic and/or recurrent anal cancer. Most of the 53 reported symptoms related to bowel, urinary, and sexual functioning, with 60% covered by the QLQ-ANL27 or the QLQ-C30. Issues not captured include, for example, neuropathy, hair loss, musculoskeletal problems, urinary incontinence, and embarrassment.</p><p><strong>Conclusion: </strong>There is a paucity of research looking specifically at QoL outcomes of patients with metastatic or recurrent anal cancer. Whilst the QLQ-ANL27 captures most QoL issues affecting these patients, it might require adapting to improve its sensitivity.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"475"},"PeriodicalIF":2.8,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dissemination planning in exercise oncology trials-a systematic review of trial protocols.","authors":"Emily Smyth, Lydia Politi, Emer Guinan, David Mockler, Linda O'Neill","doi":"10.1007/s00520-025-09532-4","DOIUrl":"https://doi.org/10.1007/s00520-025-09532-4","url":null,"abstract":"<p><strong>Purpose: </strong>The paucity of exercise rehabilitation services for cancer survivors indicates a research-to-practice gap. Dissemination and Implementation research addresses this gap by focusing on the adoption, implementation, and sustainability of evidence-based interventions. Dissemination, the active process of sharing research findings, is critical to the implementation of evidence-based practice. This systematic review examined adherence of exercise oncology trial protocols to the SPIRIT 2013 checklist items pertaining to dissemination planning, items 31a, 31b, and 31c, which address how dissemination is planned, authorship eligibility is considered, and what plans are in place to share data and the protocol.</p><p><strong>Methods: </strong>A systematic review was conducted following the PRISMA guidelines. EMBASE, MEDLINE, CINAHL, Web of Science-Core Collection, Google Scholar, and the Central Trial Registry via Cochrane were searched (16/05/2024). Title and abstract screening, full-text review, and data extraction were completed in duplicate.</p><p><strong>Results: </strong>Eighty-six trial protocols were included, thirty-one (36.1%) did not report dissemination plans. Item 31 was reported as follows (n = number of trials, frequency (%)); 31a plans to communicate trial results to: participants (n = 19, 22.1%), healthcare professionals (n = 43, 50%), the public (n = 25, 29.2%), and other relevant groups (n = 22, 25.6%), 31b: author eligibility (n = 3, 3.5%) and plans regarding use of professional writers (n = 4, 4.7%), and 31c plans for granting access to participant level dataset (n = 28, 32.6%), full protocol (n = 1, 1.2%) and statistical code (n = 1, 1.2%). Peer-reviewed journal (n = 41, 47.67%) and conferences/professional meetings (n = 38, 44.2%) were the most frequently reported planned dissemination strategies.</p><p><strong>Conclusion: </strong>Reporting of the SPIRIT 2013 checklist Item 31 is generally low in exercise oncology trial protocols. Greater consideration of dissemination planning is required to support the implementation of exercise oncology research into practice.</p><p><strong>Registration: </strong>https://doi.org/10.17605/OSF.IO/M8HFP.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"473"},"PeriodicalIF":2.8,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The experience and needs of self-care in elderly colorectal cancer stoma patients: a qualitative study.","authors":"Yan Xue, Kaili Lv, Chenye Yuan, Guidi Fan, Ping Yu","doi":"10.1007/s00520-025-09530-6","DOIUrl":"https://doi.org/10.1007/s00520-025-09530-6","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to describe the real experiences and needs of stoma self-care in elderly colorectal cancer patients, providing a theoretical basis for healthcare professionals to develop effective intervention measures.</p><p><strong>Methods: </strong>Semi-structured, in-depth interviews were conducted with the thirteen elderly colorectal cancer patients with stomas. These interviews were audio-recorded and transcribed verbatim. The interview data were then organized, analyzed, and thematically refined using Colaizzi's 7-step analysis method.</p><p><strong>Results: </strong>This study extracted three overarching themes and seven corresponding sub-themes. Theme one, actively seeking help, encompassed pre-rehabilitation needs, social support needs, and continuity of care needs. Theme two, new challenges posed by stomas, included sub-themes related to changes in daily life and psychological burdens. Theme three, courageous acceptance and proactive coping, comprised cognitive changes and behavioral changes as its sub-themes.</p><p><strong>Conclusion: </strong>The study's findings suggest that inadequate in-hospital stoma care education and a lack of continuity of care at home can result in heightened challenges for elderly patients. Healthcare professionals should implement a personalized, full-process education program tailored to geriatric patients' specific needs, ensuring seamless care transition and coordinated management between hospital and home environments.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"474"},"PeriodicalIF":2.8,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of the usefulness of protocol-based magnesium supplementation for hypomagnesemia in patients with advanced or recurrent colorectal cancer treated with panitumumab.","authors":"Daisuke Ito, Hiroki Asano, Michio Kimura, Eiseki Usami","doi":"10.1007/s00520-025-09531-5","DOIUrl":"https://doi.org/10.1007/s00520-025-09531-5","url":null,"abstract":"<p><strong>Purpose: </strong>Panitumumab (Pmab) is associated with a higher incidence and severity of hypomagnesemia compared to cetuximab, necessitating appropriate monitoring and management strategies. This study aimed to evaluate the efficacy of protocol-based magnesium (Mg) supplementation for treating hypomagnesemia in patients with advanced or recurrent colorectal cancer receiving Pmab.</p><p><strong>Methods: </strong>In this retrospective study, patients with colorectal cancer treated with Pmab between October 2010 and September 2023 were divided into two groups: the pre-protocol group (n = 30) and the post-protocol group (n = 30). The incidence of hypomagnesemia was compared between the groups. The hypomagnesemia management protocol included Mg supplementation at grade 1 (< LLN-1.2 mg/dL), initially with 20 mL (1 mEq/mL) of Mg sulfate injection. If Mg levels continued to decrease despite supplementation, the dose was increased to 40 mL (1 mEq/mL).</p><p><strong>Results: </strong>No significant difference was observed in the frequency of hypomagnesemia between the pre-protocol (56.7%, 17/30) and post-protocol (53.3%, 16/30) groups (P = 1.000). However, the incidence of grade 3 or higher hypomagnesemia was significantly lower in the post-protocol group than in the pre-protocol group (3.3%, 1/30 vs. 30.0%, 9/30; P = 0.012). The rate of deterioration from grade 1 to grade 3 or higher in patients who received Mg supplementation was significantly lower in the post-protocol group than in the pre-protocol group (6.3%, 1/16 vs. 60.0%, 9/15; P = 0.002).</p><p><strong>Conclusion: </strong>Early Mg supplementation effectively reduced the incidence of severe hypomagnesemia, highlighting the utility of this protocol in managing hypomagnesemia in Pmab-treated patients.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 6","pages":"472"},"PeriodicalIF":2.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}